Concerns towards a series of multinational companies’ use patent defenses
Original pharmaceutical products have successfully defended their use patents.
The first case was Pfizer’s Lyrica(pregabalin). Validity of the drug’s use patent was accepted in handling pains by the Supreme Court, followed by the 1st and 2nd trials filed by CH HealthCare and Samjin Pharm at the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
